Evaluation of prospective detection of PML-RARA and RARA-PML fusion transcripts by real-time quantitative PCR (RQ-PCR) to direct pre-emptive therapy with arsenic trioxide (ATO) in acute promyelocytic leukemia (APL) patients treated in the UK MRC AML15 trial.

被引：3
|
作者：
Grimwade, David J. [1 ]
Jovanovic, J. [1 ]
Hills, R. [2 ]
Nugent, E. [1 ]
Patel, Y. [3 ]
Flora, R. [1 ]
Diverio, D. [1 ]
Jones, K. [1 ]
Aslett, H. [1 ]
Sellwood, E. [4 ]
Solomon, E. [1 ]
Lo Coco, F. [5 ]
Wheatley, K. [4 ]
Burnett, A. [2 ]
机构：
[1] Univ Wales Coll Cardiff, KCL, Dept Genet, Cardiff CF1 3NS, S Glam, Wales
[2] Univ Wales Coll Cardiff, Dept Haematol, Cardiff CF1 3NS, S Glam, Wales
[3] UCL, Dept Haematol, London, England
[4] Univ Birmingham, Clin Trial Unit, Birmingham B15 2TT, W Midlands, England
[5] Univ Roma Tor Vergata, Dept Hematol, Rome, Italy
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.541.541
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
541
引用
收藏
页码：166A / 167A
页数：2
相关论文
共 6 条
  • [1] Real-time detection of PML-RARA and RARA-PML fusion transcripts in high risk acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO):: Implications for realization of pre-emptive therapy for molecular relapse.
    Grimwade, David
    Jovanovic, J. V.
    Diverio, D.
    Nugent, E.
    Ho, A. Y.
    Mufti, G. J.
    Hills, R. K.
    Solomon, E.
    Clark, R. E.
    Lo Coco, F.
    Burnett, A. K.
    BLOOD, 2006, 108 (11) : 149A - 150A
  • [2] EVALUATION OF A REAL-TIME PCR SYSTEM TO QUANTIFY PML-RARA FUSION TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA
    Murugesan, Gurunathan
    Dennis, Janay
    Guenther-Johnson, Jeanna
    Frank, Mularo
    Cook, James
    Daly, Thomas
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 77 - 77
  • [3] Qualitative and Quantitative Correlation of PML-Rara Fusion Transcript from Peripheral Blood and Bone Marrow Samples By Quantitative Real-Time PCR in Patients with Acute Promyelocytic Leukemia
    Sasaki, Koji
    Kantarjian, Hagop M.
    Luthra, Raja
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Estey, Elihu H.
    Kadia, Tapan
    Brandt, Mark
    Pierce, Sherry
    Estrov, Zeev
    Ferrajoli, Alessandra
    Borthakur, Gautam
    Cortes, Jorge E.
    Ravandi, Farhad
    BLOOD, 2015, 126 (23)
  • [4] Quantitative kinetics of PML/RARa transcripts using real-time RT-PCR according to the use of cytarabine for consolidation in patients with newly diagnosed acute promyelocytic leukemia: A prospective randomized trial.
    Seok, L
    Kim, YL
    Hwang, JY
    Kim, YJ
    Park, YH
    Shin, HJ
    Park, CY
    Min, CK
    Kim, DW
    Lee, JW
    Min, WS
    Kim, CC
    BLOOD, 2001, 98 (11) : 194B - 194B
  • [5] Evaluation of prospective real-time quantitative PCR monitoring for minimal residual disease to predict relapse and direct molecularly targeted therapy with arsenic trioxide in acute promyelocytic leukaemia: analysis of 407 patients, including results of the MRC AML15 trial
    Grimwade, D.
    Jovanovic, J. V.
    Hills, R. K.
    Nugent, E. A.
    Patel, Y.
    Flora, R.
    Diverio, D.
    Jones, K.
    Aslett, H.
    Batson, E.
    Clark, R. E.
    Solomon, E.
    Lo Coco, F.
    Wheatley, K.
    Burnett, A. K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 59 - 59
  • [6] Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) On Peripheral Blood (PB) and Bone Marrow (BM) Samples for Monitoring Minimal Residual Disease (MRD) in Patients (pts) with Acute Promyelocytic Leukemia (APL) Treated with All-Trans-Retinoic Acid (ATRA) and Arsenic Trioxide (ATO).
    Ghanem, Hady
    Kantarjian, Hagop M.
    Faderl, Stefan
    Jabbour, Elias J.
    Daver, Naval
    Pierce, Sherry A.
    Brandt, Mark
    Quintas-Cardama, Alfonso
    Luthra, Rajyalakshmi
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    BLOOD, 2012, 120 (21)
1